CSW Industrials, Inc. (NYSE: CSW) — The Earnings Proof Arrived Before the ROIC Proof

Research update dated September 3, 2026. Fiscal years end March 31. Dollar amounts are U.S. dollars unless stated otherwise.

⚡ Claude’s Take

Rating: HOLD / accumulate only on meaningful weakness. Conviction: medium. At $301.80, CSW is a better business than it looked in July but not a cheaper security. Fiscal Q1 answered two of the three questions that made the FY2026 acquisition binge unsettling: consolidated organic revenue returned to +5.3%, with both price and volume positive, and management says MARS has already sustained a 30% EBITDA margin for two quarters while realized cost synergies reached $13 million. The filing supports the direction even if it cannot verify MARS separately: Contractor Solutions operating margin recovered to 27.2%, consolidated operating margin reached 22.8%, and free cash flow rose to $69.6 million. The operating bear case has therefore weakened.

The capital-allocation question has not been answered. Filing-derived trailing ROIC is approximately 9.6%, or 10.4% excluding the Greco impairment; on the current ending capital base it is only 7.8%–8.5%. Those figures are better interpreted as “not yet proven” than “failed,” because MARS closed only in November 2025, but they still sit well below the mid-teens returns that would validate more than $1 billion of FY2026 acquisitions. MARS at a 30% margin on its disclosed revenue run rate produces only about a 6.6% pre-tax EBITDA yield on purchase price before financing and tax. Integration execution is running ahead of plan; acquisition economics remain expensive.

At the September 2 close, CSW has a $4.92 billion market capitalization and approximately $5.75 billion enterprise value. That is 19.0× trailing company-adjusted EBITDA, 21.5× GAAP EBITDA, about 37× normalized earnings that retain recurring amortization and interest, and a 2.9% free-cash-flow yield. A reverse DCF requires roughly 18%–20% annual five-year growth in current free cash flow to the firm, depending on the starting normalization. The price already grants substantial credit for the Q1 proof points.

My reasonable-value zone rises from July’s $210–$245 to $265–$290. The increase recognizes earlier MARS synergies, restored organic growth, stronger segment margins, better cash conversion, and initial deleveraging. The upper end effectively capitalizes a forward EBITDA run rate near $325 million at roughly 18× after current net debt; the lower end is close to 17× trailing adjusted EBITDA. That remains a demanding range for a company earning around its cost of capital, but CSW’s best niche brands and cash generation deserve a premium to ordinary industrials. I would not short it: a hot summer, continued 4%–6% organic growth, and MARS cross-selling could make today’s earnings base conservative. I also would not chase it above $300 before returns on the enlarged capital base follow the margin recovery.

What changes my mind. The bullish upgrade is two more quarters of organic growth above 4%, Contractor operating margin above 25%, credit leverage below 2×, and filing-derived ROIC above 12% with a visible path toward 15%. The bearish break is organic volume turning negative after pricing and anniversary effects, MARS/Aspen margin regression, leverage stalling above 2.5×, or another large acquisition before the existing capital earns clearly above its cost. The next two filings matter more than management’s acquisition pipeline.

Changes Since July 4, 2026

The July thesis was “high-quality core, expensive acquisition experiment, insufficient evidence.” The evidence has changed in five important ways.

There is also a regulatory correction. The earlier analysis leaned too heavily on a forced repair-to-replacement shift from the refrigerant transition. The EPA’s current HFC guidance permits R-410A service components for legacy systems after 2025 without a specified sales sunset. That supports a continuing repair market for MARS and Aspen as well as new-system demand. Regulation changes product mix and inventory timing; it does not create a one-way replacement mandate.

Finally, the stock incorporated the good news. It rose from $276.12 on July 2 to $301.80 on September 2, even after retreating from its post-earnings high. The investment debate is no longer whether management can integrate MARS at all. It is whether one strong quarter can compound fast enough to justify a premium multiple before ROIC confirms the value creation.

📈 Stock Price Action — Five-Year Event Map

Price moves are facts; attributed causes are interpretations. This is context, not a trading recommendation.

AZI’s split- and dividend-adjusted history shows CSW falling from $128.14 on September 3, 2021 to a five-year low of $95.49 on June 17, 2022, then climbing to an all-time closing high of $429.17 on November 25, 2024. The rise paired margin expansion with enthusiasm for the A2L refrigerant transition. The subsequent reset reflected normalization fears, acquisition dilution, higher interest expense, and a broad compression in richly valued small-cap industrials. The September 2, 2026 close of $301.80 is 29.7% below the peak but 216% above the trough.

The five-year arc is useful because it separates company quality from entry price. CSW has repeatedly earned a premium when organic growth and margins reinforce one another; it has also repeatedly lost that premium when refrigerant timing or M&A obscures underlying demand. The current price is neither a distressed low nor a momentum peak. It is a “show me the returns” price after management successfully cleared the first integration hurdle.

The quantitative tape is mixed. The close sits below the 21-day and 50-day exponential moving averages of $321.35 and $310.64, but above the 200-day average of $291.47; the 50-day remains above the 200-day. Adjusted returns are +11.4% over three months, +8.6% over six months, and +13.6% over twelve months. Five-year annualized return was 18.6%, but annualized volatility was 34.4% and maximum drawdown 46.2%.

FactorsToday’s current loadings characterize CSW as a high-beta small/mid-cap industrial rather than a pure quality or momentum exposure. The base model shows Market +1.235, Dividend Yield +0.600, Small Size +0.444, Quality +0.187, Momentum +0.180, and Growth -0.258; specific volatility is 34.7%, and only about half of variance is explained in the broader model. Related factor profiles include Applied Industrial, Kadant, Eagle Materials, Quanex, Rush Enterprises, Moog, and Watsco. Recent Momentum and Quality factor returns have been weak while Small Size, Value, and Dividend Yield have been favorable; no regime z-score exceeds 2. The signal is supportive in places but not extreme enough to substitute for company fundamentals.

1. Executive Summary

CSW Industrials is a Dallas-based diversified industrial company that sells small-ticket, mission-critical products into HVAC/R, plumbing, electrical, industrial MRO, and commercial-building applications. It was spun out of Capital Southwest in 2015 and changed its ticker from CSWI to CSW when it moved from Nasdaq to the NYSE in June 2025. The company is now dominated by Contractor Solutions, which represented 74.2% of FY2026 external revenue and 78.0% in fiscal Q1 2027. Specialized Reliability Solutions, or SRS, contributed 14.8% of FY2026 revenue, while Engineered Building Solutions, or EBS, contributed 11.1%.

The commercial proposition is straightforward. A tube of sealant, condensate switch, motor, coil, access door, smoke curtain, lubricant, or fitting is usually a small share of the customer’s project cost but can prevent a callback, a code failure, or equipment downtime. That asymmetry supports willingness to pay for recognized brands, availability, and application reliability. It also explains why the best CSW products can earn attractive margins without patents or network effects. The FY2026 Form 10-K describes RectorSeal No. 5 as an industry standard and Whitmore’s Kopr-Kote as requested by name. Those are credible signs of product-level customer captivity, not proof of an enterprise-wide moat.

The earnings model is short cycle and asset light. Approximately 90% of FY2026 revenue was built to stock or book-and-ship, usually within one week; only 9.8%, all in EBS, was built to order with lead times up to twelve weeks. Installation was about 2% of sales. Capital expenditure has remained 1.6%–2.5% of revenue over the last five fiscal years, and free cash flow exceeded net income in four of those five years. This is a distributor-facing product portfolio rather than a long-duration construction contractor.

The strategic issue is that acquisitions have changed the financial identity faster than they changed the operating identity. CSW spent more than $1 billion across MARS Parts, Aspen Manufacturing, Duckt-Strip, Hydrotex, and ProAction in FY2026. It went from $226 million of net cash in FY2025 to $838 million of net debt in FY2026. Goodwill and identifiable intangible assets reached $1.53 billion, leaving tangible equity negative. Organic revenue declined 2.1%, gross margin fell 290 basis points, and GAAP EPS fell 20% even as reported revenue rose 23.3%.

Fiscal Q1 2027 is the first clean evidence that integration can reverse those symptoms. According to the July 30 Form 10-Q, revenue rose 33.0% to $350.7 million, organic growth was 5.3%, gross margin expanded 110 basis points to 44.9%, operating margin expanded 200 basis points to 22.8%, and diluted EPS increased 25% to $3.04. Free cash flow rose 20.6%. Contractor operating margin reached 27.2%, slightly above the prior-year quarter despite a much larger acquired mix. SRS also improved, while EBS remained mixed because Greco continued to contract.

This is economically meaningful but statistically thin. Q1 organic growth includes two months of Aspen after its acquisition anniversary, and favorable summer HVAC conditions can flatter a single quarter. Management also stopped disclosing MARS as a stand-alone operation after integrating it. The 30% margin assertion is therefore supported by segment direction but not independently calculable from the filing.

The competitive assessment is balanced. CSW possesses narrow demand advantages in trusted, specified, or qualification-intensive applications. It does not possess a network effect, and its supply advantage is modest because competitors can reproduce formulations and source overlapping products. DiversiTech, Nu-Calgon, Oatey, and other vendors offer broad assortments and fulfillment. Watsco and other large distributors aggregate demand and can rationalize suppliers. The moat is strongest in SRS applications where failure costs and requalification matter, and in Contractor brands whose reliability avoids service callbacks. It is weakest in generic sourced SKUs.

The industry backdrop is supportive but not euphoric. The installed base of HVAC equipment creates recurring repair demand; plumbing and life-safety products benefit from code and replacement cycles; and physical capacity investment across CSW remains restrained. Yet acquisition capital is flowing into the same niches. Lennox has acquired adjacent HVAC parts businesses, while Watsco continues to consolidate distribution. The capital-cycle risk is not a glut of factories. It is higher prices for attractive brands, followed by lower returns on acquired goodwill.

Financial quality has recovered faster than capital efficiency. Trailing revenue is approximately $1.170 billion, GAAP operating income $193.5 million, GAAP EBITDA $267.5 million, company-adjusted EBITDA $302.6 million, and free cash flow $144.3 million. The gap between GAAP and adjusted results is unusually important: acquired-intangible amortization is non-cash, but it represents the recurring consumption of assets bought with real capital. Both views should be shown. The same discipline applies to leverage: management’s credit-agreement ratio was 2.37×, while current net debt divided by trailing adjusted EBITDA is about 2.68×. Neither is dangerous, but neither recreates the old fortress.

Capital allocation is mixed. The pre-FY2026 acquisition cohort coincided with higher Contractor margins and appears productive at segment level. Aspen was bought at a more defensible price than MARS, and smaller bolt-ons were inexpensive. MARS’s integration is ahead of plan, but 98.8% of its purchase price was goodwill and intangibles. Incentives still emphasize absolute EBITDA and operating cash flow rather than organic growth, ROIC, or per-share value. In FY2026 the board adjusted incentive OCF upward by $55.2 million for acquisition-related effects even though reported OCF fell 11%, producing a 158.9% payout on that component. Relative-TSR awards and ownership guidelines provide offsetting alignment.

The core conclusion is therefore precise: the July operating skepticism needs to be reduced, while the July capital-return skepticism remains intact. CSW has shown that it can integrate MARS operationally. It has not shown that the purchase price will earn mid-teens returns after interest, tax, and the full capital denominator. At today’s valuation, the market requires much of that second proof in advance.

2. Business Overview

Contractor Solutions

Contractor Solutions sells HVAC/R, plumbing, electrical, and building-products consumables and components primarily through wholesalers and distributors. Its brands include RectorSeal, Shoemaker, Smoke Guard, Aspen, MARS, and a long list of acquired specialty franchises. Products range from pipe-thread sealants and condensate-management devices to grilles, registers, motors, capacitors, coils, air handlers, line-set covers, electrical accessories, and installation tools.

The segment’s value proposition is less about proprietary technology than about reducing transaction and failure costs. A contractor arriving at a job wants the correct component available locally, wants confidence that the installed product will work, and does not want an avoidable callback. A distributor wants high turns, consolidated purchasing, reliable fulfillment, and a broad enough line to reduce vendors and shipments. CSW’s acquisition strategy assembles more items that can sit on the same distributor shelf or service truck.

That model can be powerful when brand and availability reinforce one another. It can also be overstated. Competitors such as DiversiTech, Nu-Calgon, and Oatey advertise overlapping breadth and fulfillment. A broader catalog is useful, but it is not unique. The scarce assets are the subset of named products, field trust, and installed distributor relationships—not the mere number of SKUs.

FY2026 external Contractor revenue was $802.7 million. In Q1 it was $273.6 million, or 78.0% of consolidated sales. Reported segment revenue rose 40.3%, of which acquisitions contributed 34.4% and organic growth 5.9%. Operating income rose 42.2% to $75.0 million, and margin increased to 27.2% from 26.8%. That is the strongest filing-based evidence that MARS and Aspen are no longer mechanically diluting the segment.

Specialized Reliability Solutions

SRS sells specialty lubricants, compounds, sealants, cleaners, degreasers, and lubrication-management products for harsh industrial applications. The customer proposition is avoided downtime and longer asset life. The price of the lubricant is small relative to the value of a kiln, mine conveyor, railcar, compressor, or other critical equipment. Once an application has been proven, switching can require testing and exposes the operator to failure risk. That produces higher customer captivity than a generic Contractor SKU, although large oil and lubricant companies remain credible competitors.

SRS generated $160.0 million of FY2026 external revenue. Q1 segment revenue rose 30.9% to $48.2 million: acquired growth was 14.5% and organic growth was 16.5%, supported by both volume and price. Operating margin expanded 250 basis points to 16.7%, and adjusted EBITDA margin reached 20.8%. The quarter benefited from mining and general-industrial demand, so the run rate should not be extrapolated mechanically. Still, it demonstrates that the smaller industrial portfolio can contribute rather than merely diversify.

Engineered Building Solutions

EBS sells code-driven fire, smoke, and life-safety products plus architectural building components. Unlike the rest of CSW, it has a meaningful build-to-order component and more exposure to project timing. Products can be specified into a building, tested within a rated assembly, or required by code. International Building Code provisions create demand for rated opening protectives and firestopping, but multiple vendors can qualify; code is a hurdle, not an exclusive franchise.

The segment contains both a good Smoke Guard business and the Greco mistake. FY2026 EBS revenue was $119.9 million, operating income was negative $1.2 million after a $15.6 million impairment, and management decided to exit Greco’s U.S. operation and wind down Canadian exposure. Q1 revenue fell 9.3% to $28.9 million, yet operating margin recovered to 15.8%. Excluding Greco, revenue rose 7% and adjusted EBITDA margin reached 26.2%; management appropriately cautioned that mid-20s margins are not yet a normal assumption. Four-quarter book-to-bill was 1.04 with record backlog, which offers support but matters to less than one-tenth of consolidated book-and-ship sales.

Geographic and operating structure

CSW manufactures in the United States, Vietnam, and Canada and distributes from those countries plus Australia and the United Kingdom. It sells into more than 100 countries but remains primarily North American. Contractor sourcing is diversified but not insulated: management described roughly 45%–50% of cost of goods sourced domestically, low-30s from Vietnam, high-single digits from Thailand, and around 10% from China. Acquisitions repeatedly reintroduce China exposure even as the legacy portfolio diversifies it.

The portfolio shares channels and operating methods more than technology. Contractor and SRS benefit from cross-selling, sourcing, and continuous-improvement systems; EBS has a different project/specification rhythm. Corporate decentralization preserves brand expertise while central capital allocation and operating initiatives seek margin improvement. The arrangement works if CSW buys durable niche franchises at sensible prices and accelerates them without destroying local customer trust. It becomes a conglomerate discount candidate if growth is purchased faster than the organization can generate returns.

3. Industry Dynamics

The most relevant market is not “industrials” broadly. It is the intersection of HVAC/R replacement parts and consumables, plumbing and electrical trade products, industrial MRO specialties, and code-driven building products. These are fragmented categories with many small suppliers, powerful distributors, and a mix of recurring replacement and cyclical construction demand.

Watsco’s 2025 Form 10-K estimates the North American HVAC/R distribution market at $74 billion, with more than 2,100 distribution companies. Its 695 locations serve over 130,000 active contractors, while eight OEMs account for about 90% of equipment shipments. Nearly half the market is non-equipment, and Watsco buys $1.7 billion of products from more than 1,500 non-equipment vendors. This frames CSW’s opportunity and its constraint: the addressable pool is large, but the distributor owns demand aggregation and has real supplier-rationalization power.

HVAC demand has three overlapping cycles. New residential and non-residential construction drives new installations; weather drives near-term service volumes; and the installed equipment base creates replacement and repair demand that persists through weaker building cycles. Refrigerant regulation adds a fourth timing factor by changing product design and channel inventory. AHRI’s June 2026 release showed central-air-conditioner and air-source-heat-pump shipments up 21.7% year over year in June but only 3.0% for the first half. AHRI explicitly warns that shipments are not a market forecast. The data indicate a strong month, not a structural boom.

Peer evidence is mixed. Watsco’s Q2 2026 release reported domestic residential-equipment sales up 5%, including 2% unit growth and 2% price, while other HVAC products fell 1%. Lennox reported Home Comfort revenue down 7% on lower volume and new-construction softness, while Building Climate organic revenue grew 15%. CSW’s quarter was stronger than those imperfect benchmarks, but weather, product mix, and acquisition anniversaries differ too much to label the gap durable share gain.

The refrigerant transition is supportive but two-sided. Lower-global-warming-potential A2L refrigerants require compatible equipment and components, encouraging product refresh and distributor stocking. Yet the EPA permits service components for legacy R-410A systems after 2025. That extends the repair tail and reduces stranded-inventory risk for components. It also means the investor narrative should focus on mix, compliance, and installed-base breadth rather than a forced cliff from repair to replacement.

Plumbing, electrical, and life-safety demand is steadier but not immune to construction. Codes create required categories, and professional installers value availability and field reliability. Industrial MRO is tied to utilization in mining, energy, rail, and general manufacturing; the cost of downtime supports specialty margins, but commodity cycles change volumes.

From a capital-cycle perspective, physical supply is healthy. CSW’s capex/depreciation ratio remained close to 1.1× in FY2024–FY2026, and capex was only 1.7% of trailing sales. There is no evidence of reckless factory construction. Financial capital is less disciplined. CSW deployed over $1 billion in one year; Lennox bought Duro Dyne/Supco and Heat Controller; Watsco says twelve acquisitions since 2019 added $1.6 billion of annual sales. Good niches attract buyers, purchase multiples rise, and future acquirers risk capitalizing the seller’s economics rather than creating their own.

Industry structure is therefore mixed-positive. Replacement demand, small-ticket criticality, codes, and fragmented suppliers support gross margins. Distributor and OEM concentration, substitutable sourced products, volatile input and freight costs, and hot M&A capital limit excess returns. The profit pool should remain concentrated in trusted brands, specified products, qualification-heavy applications, and vendors that reliably earn shelf space—not in generic production capacity.

4. Competitive Position

Moat classification

The most defensible description is a narrow, product-level demand advantage. CSW does not have a network effect: one contractor’s use does not make the product more valuable to another. It does not have an obvious proprietary supply advantage because competitors can formulate similar chemicals, stamp metal, source motors and capacitors, or build overlapping assemblies. Enterprise-scale economics are possible in sourcing, fulfillment, and sales coverage, but are not demonstrably unique because rivals and distributors often have greater breadth.

Customer captivity varies by segment and product. In Contractor Solutions, habitual purchasing, distributor shelf presence, recognized packaging, and callback avoidance create low-to-moderate switching costs. A contractor can change brands, but may not want to risk a failed seal or spend time evaluating an unfamiliar product when the item is a tiny fraction of the job. In SRS, a lubricant proven in severe service may require requalification and exposes expensive machinery to failure, creating moderate-to-high switching costs. In EBS, specification and testing create moderate project-level captivity after selection but do not prevent a rival from winning the next design.

This distinction matters because “distribution breadth” can sound like a network moat when it is really a negotiated channel advantage. DiversiTech markets equipment mounting, condensate, electrical, replacement-parts, tools, indoor-air-quality, and consumable families. Nu-Calgon offers a broad HVAC specialty-chemical line and 24-hour fulfillment. Oatey sells thousands of plumbing products with a one-invoice, one-shipment proposition. Competitors validate the value of CSW’s model while disproving its uniqueness.

Evidence for pricing power

Margins provide better evidence than brand descriptions. Contractor operating margin was 23.1% in FY2022, 24.6% in FY2023, 26.5% in FY2024, and 26.9% in FY2025 before falling to 21.7% in acquisition-heavy FY2026. Q1 recovered to 27.2%. Consolidated gross margin expanded from 40.9% in FY2022 to 44.8% in FY2025, fell to 41.9% after Aspen and MARS, and returned to 44.9% in Q1. A portfolio with no customer value advantage would struggle to sustain those margins while passing through materials and freight.

Management implemented a 3%–5% Contractor price increase in July to offset steel, aluminum, plastics, and freight, and price was already positive in Q1. It characterized the increase as cost recovery, not margin expansion. That is a more credible signal than claiming unconstrained pricing power. The real test is whether unit volume remains positive after the increase reaches distributor and contractor demand.

Evidence against a wide moat

The strongest enterprise test is return on invested capital, and CSW does not pass it consistently. A long third-party series, checked directionally against filings, shows only FY2019 and FY2020 above 15%; FY2026 fell near 8%–9%, and the current filing reconstruction is 9.6%. A narrow set of excellent brands can coexist with mediocre consolidated returns when management pays sellers for the franchise value. The acquisition price transfers some moat economics from shareholders to the seller.

Market-share stability cannot be tested rigorously. CSW does not publish five-to-eight-year product-niche share data; acquisitions repeatedly change the denominator; and public competitors do not disclose directly comparable shares. Revenue growth above an end-market benchmark could be share gain, cross-selling, price, product mix, or acquired revenue. Any assertion of durable share gain would exceed the evidence.

Buyer power is also real. No direct customer represents 10% of CSW’s consolidated revenue, which limits single-account risk, but the distribution tier is consolidating and can choose among many vendors. Watsco’s scale and supplier-rationalization efforts show how value can accrue to the channel. CSW can counter with recognized brands and a broader basket; it cannot eliminate negotiation.

Competitive scorecard

The competitive position is good enough to support premium segment margins and recurring cash generation, but not strong enough to make purchase price irrelevant. This is exactly why MARS integration and all-in ROIC must be analyzed separately: operational quality can be high even when the acquisition return is ordinary.

5. Growth History and Forward Opportunities

CSW has compounded reported revenue rapidly, but acquisitions have supplied most of the recent dollars. Organic/acquired growth was +24.8%/+24.6% in FY2022, +15.3%/+5.7% in FY2023, +3.1%/+1.5% in FY2024, +4.8%/+6.0% in FY2025, -2.1%/+25.3% in FY2026, and +5.3%/+27.7% in Q1 FY2027. Across FY2022–FY2026, acquisitions generated approximately 63% of the roughly $663 million revenue increase, while inflationary pricing contributed significantly to the early organic period.

The organic opportunity has four components. First, CSW can place more of its basket in existing distributor branches and contractor trucks. MARS and Aspen broaden the replacement-parts offering and give salespeople more reasons to call on the same account. Second, product introductions and refrigerant-compatible components can win refresh demand. Third, recognized brands can recover input inflation through price. Fourth, the installed HVAC base, plumbing repair, industrial maintenance, and building codes provide recurring volume.

Q1 demonstrates that all four need not work simultaneously for attractive growth. Contractor organic revenue rose 5.9%, SRS rose 16.5%, and EBS declined 9.3% because of Greco. Management cited HVAC/R, general industrial, plumbing, and mining strength, offset by architecture, rail, and electrical softness. This diversity reduces dependence on a single end market but does not remove short-cycle volatility.

The principal near-term complication is the organic convention. Aspen closed May 1, 2025, so two months of its current-quarter sales counted as organic against prior ownership even though investors may intuitively treat the business as acquired. MARS will become organic in November 2026. Aspen also faces difficult comparisons tied to the prior refrigerant and canister transition. Reported organic growth can therefore change because of anniversary accounting as well as same-product demand.

MARS creates the largest self-help opportunity. Management initially targeted more than $10 million of cost synergies and a 30% EBITDA margin by the first anniversary. It now reports $13 million of run-rate synergies and two consecutive quarters at 30%. Future value must come from sustaining those savings, rationalizing duplicate SKUs, selecting the best lower-cost products, and cross-selling rather than cutting the same cost twice. Standalone disclosure has ended, so investors must infer progress from Contractor margin, organic growth, working capital, and ROIC.

SRS can add steadier growth through product qualification and acquired Hydrotex/ProAction capabilities, but mining and industrial demand are cyclical. EBS has a narrower path: exit loss-making Greco operations, protect Smoke Guard, and convert record backlog without treating a single 26% adjusted EBITDA margin quarter as the norm. Management’s longer-term “well within the 20s” aspiration is plausible only if Greco losses disappear and project mix remains favorable.

Future acquisitions are both opportunity and risk. Management describes a robust smaller-deal pipeline and says the heavy integration phase is largely complete. Bolt-ons bought near 5× EBITDA can create value when attached to existing channels. Another MARS-sized transaction before leverage and ROIC recover would reset the proof period and increase the chance that reported growth outruns per-share value.

The most useful forward growth test is not consolidated revenue. It is a four-part bridge: price, unit volume, acquisition anniversaries, and cross-selling. Sustained organic growth above 4% after MARS becomes organic, combined with Contractor margin above 25% and a falling capital denominator through cash generation, would indicate that the acquired platform is compounding. Growth below inflation with renewed acquisitions would indicate that CSW is buying the appearance of momentum.

6. Financial Quality

Five-year financial record

The financial history separates an improving legacy franchise from a disruptive acquisition year. This table is reconstructed from the FY2024, FY2026, and Q1 FY2027 filings. Free cash flow is operating cash flow less capital expenditure.

FY2026 was not a normal deterioration in the existing portfolio. Aspen and MARS brought lower initial gross margins, purchase accounting increased amortization, integration costs rose, interest expense replaced interest income, and Greco produced a $15.6 million impairment. Organic unit volume also declined. Revenue rose 23.3%, yet GAAP diluted EPS fell from $8.38 to $6.70.

Q1 began to close that gap. Revenue rose 33.0%, gross profit 36.4%, operating income 45.5%, and diluted EPS 25.1%. The 22.8% operating margin was 200 basis points above the prior-year quarter. Expenses grew more slowly than sales, and gross margin expanded despite a larger acquired mix. This was genuine operating leverage, not acquisition arithmetic alone.

GAAP, adjusted, and economic earnings

Three lenses are useful. Trailing GAAP EBITDA is approximately $267.5 million. Adding only Greco’s impairment gives $283.1 million. The company’s broader adjusted definition is about $302.6 million and excludes acquired-intangible amortization and integration items. Trailing additive EPS is about $7.31 GAAP and $11.37 adjusted.

Neither endpoint should stand alone. Acquired-intangible amortization is non-cash today and can obscure current cash generation. It is also the accounting consumption of customer lists and brands purchased with real capital; removing it forever while ignoring acquisition outlays overstates economics for a serial acquirer. A normalized EPS near $8.1 keeps recurring amortization and cash interest but removes the Greco impairment and exit noise. The adjustment is intentionally more conservative than management’s comparability measure.

The covenant definition is even more permissive. Q1 credit-agreement EBITDA was $343.8 million because it included $23.6 million of pro-forma acquired EBITDA, $15.0 million of stock compensation, $13.8 million of transaction and integration cost, a prior-year ESOP contribution, and other items. That measure is appropriate for covenant compliance but not for economic valuation. Pro-forma EBITDA was not earned in the reported period, and recurring stock compensation is a shareholder cost.

The five annual and fifteen quarterly filings in the trailing five-year review show no restatement, disclosed material weakness, auditor change, or significant accounting-policy discontinuity. The FY2026 control assessment excluded newly acquired Aspen and Hydrotex, which represented about 16% and 1% of assets, respectively; the auditor’s scope exception specifically named Aspen. MARS was not excluded despite closing in November. That is reassuring for the largest transaction, while Aspen’s first fully integrated control-year still deserves attention.

Cash conversion and working capital

Cash generation remains a core strength. Trailing operating cash flow of $164.6 million and free cash flow of $144.3 million equal 136% and 119% of attributable net income. Capex is only 1.7% of revenue. Stock compensation is about $15.0 million, 1.3% of sales and around 10% of free cash flow: real but manageable.

Working capital still carries acquisition residue. The cash-conversion cycle lengthened from 153 days in FY2025 to 170 in FY2026 as inventory days increased. It improved modestly to about 166 days on a trailing basis; inventory days fell, but receivable days rose. In Q1, a $24.6 million receivables build was mostly offset by higher payables and accruals, lower prepaids, and a $2.2 million inventory release. Net operating working capital used only about $2 million of cash, a clear improvement rather than complete normalization.

Seasonality argues against annualizing the June quarter. Summer HVAC demand usually makes June and September the margin high-water marks; December is weaker. Management expects FY2027 free cash flow above FY2026 and approximately $48 million of interest expense. The better test is whether rolling free cash flow rises while inventory and receivables normalize.

Return on invested capital

ROIC is the central metric because acquisitions dominate capital use. Trailing NOPAT is approximately $148.7 million: $193.5 million of operating income taxed at 23.2%. Average invested capital—debt plus equity plus redeemable non-controlling interest less cash—is about $1.545 billion. That yields 9.6% ROIC, or 10.4% after adding back Greco’s impairment.

Average capital understates the burden of a transaction that closed partway through the period. On June ending invested capital of approximately $1.903 billion, the NOPAT yield is only 7.8%, or 8.5% excluding Greco. These are not mature-return forecasts; they are the honest present yields on all capital now deployed. The gap will narrow as MARS contributes for a full year.

This explains why a 30% MARS EBITDA margin is necessary but insufficient. At the disclosed revenue run rate, 30% implies about $43 million of EBITDA against $658 million paid. The core’s 20%–27% operating margins do not automatically generate high enterprise ROIC when goodwill and customer-list values enlarge the denominator. Returns must improve through organic growth, synergy, working-capital release, and debt reduction rather than through accounting adjustment.

Balance sheet and solvency

At June 30, cash was $47.5 million and gross debt $857.5 million, leaving $810.0 million of net debt, down $27.7 million in one quarter. Revolver availability was $426.2 million and the current ratio 2.70×. The company also had $19.0 million of redeemable non-controlling interest, $74.5 million of operating-lease liabilities, and $16.7 million of contingent consideration.

Covenants require maximum leverage of 3.50×, temporarily 4.00× after qualifying acquisitions, and minimum interest coverage of 3.00×. CSW was compliant. Management’s credit ratio fell to 2.37× from 2.55×; current net debt divided by trailing adjusted EBITDA is about 2.68×. Trailing EBIT covers net interest about 5.7× and EBITDA 7.9×. The balance sheet is leveraged, not stressed.

Tangible equity is negative because $640.3 million of goodwill and $884.8 million of intangibles exceed $1.074 billion of attributable book equity. The correct June deficit is approximately $452 million—not the $1.1 billion stated in July. This is not a liquidity problem, but it removes hard-asset downside protection. Shareholders rely on future franchise cash flows rather than recoverable plant and inventory.

Financial quality is thus bifurcated. Cash conversion, capex intensity, liquidity, and current margins are strong. All-in returns, working-capital efficiency, and the acquired-intangible burden remain ordinary. The next phase should be judged on ROIC and per-share free cash flow, not adjusted EBITDA growth alone.

7. Capital Allocation

Acquisition scorecard

CSW reports about $1.7 billion of cumulative acquisition investment since FY2016; roughly $1.23 billion was paid in the last five fiscal years. The strategy created much of today’s Contractor franchise, but its pace changed dramatically in FY2026.

MARS remains the load-bearing decision. Its allocation contains $259.5 million of goodwill, $354.0 million of customer lists, and a $37.0 million trade name; goodwill and intangibles equal 98.8% of the purchase price. Aspen’s equivalent ratio is 87.7%. These figures do not imply misconduct. They show that CSW bought expected franchise cash flow, not hard assets.

MARS produced $60.1 million of revenue and $3.9 million of pretax income from its November close through March, a period burdened by integration. At the annualized revenue rate, a 30% EBITDA margin equals about $43 million, a 6.6% pretax EBITDA yield or 15.2× purchase-price/EBITDA. Sustained organic growth and cross-selling are still required for an attractive post-tax return.

The older scorecard is better. From FY2022 to FY2025, Contractor revenue rose from $416.5 million to $617.3 million, operating income from $96.1 million to $165.9 million, and margin from 23.1% to 26.9%. Deal-specific returns are unavailable and price-led organic growth contributed, but the segment outcome was strong. Greco is the clear failure: a $15.6 million impairment and exit. The latest cohort has progressed from “initially dilutive” to “operationally promising,” without yet reaching “value proven.”

Buybacks, dividends, and dilution

CSW issued 1.265 million shares at $285 in September 2024 for $347.4 million net, then borrowed for acquisitions and repurchased stock. Program buybacks totaled about $128.6 million in FY2026 at roughly $248.50 per share and $23.526 million in Q1 at $267.43. Those prices were below the issuance price and September 2026 market price, so recent timing was sensible.

The broader share record is mixed. July outstanding shares of 16.293 million were 3.7% above FY2022 year-end; FY2026 weighted diluted shares were 5.7% above FY2022. The offering and compensation exceeded repurchases over the full period. Q1 diluted shares finally fell 3.0% year over year, showing current buybacks more than offset issuance.

Q1 disclosures contain a $2 million contradiction. Note 12, the equity statement, and the call report 87,970 program shares for $23.526 million, while MD&A says $25.5 million. The $36.341 million cash-flow line is broader because it includes employee award-tax withholding and other treasury activity. Use $23.526 million for discretionary repurchases and $36.341 million only for total treasury cash use.

The quarterly dividend is $0.30, or $1.20 annualized, about 16% of trailing GAAP EPS and a 0.4% current yield. Q1 program buybacks plus dividends used $28.4 million, 41% of free cash flow, while net debt fell. Trailing cash returns exceeded free cash flow because FY2026 repurchases were unusually large. Deleveraging has greater strategic value than repurchasing expensive shares if the valuation remains full.

Incentives, governance, and insiders

The 2026 proxy leaves a scale bias. Annual incentives use absolute EBITDA, operating cash flow, and individual objectives; the CEO weights were 60%, 15%, and 25%. There is no organic-growth, ROIC, or per-share metric. Absolute EBITDA can rise through debt-funded acquisition even if returns are inadequate.

Reported FY2026 OCF fell 11.1% to $149.7 million, yet the incentive calculation excluded $55.2 million of acquisition and financing effects, lifting measured OCF to $204.9 million and producing a 158.9% payout for that component. Adjustments can keep an in-year deal from distorting a target, but shareholders experienced the consolidated cash result. A post-deal ROIC or per-share FCF metric would better balance the incentive to grow.

There are offsets. Long-term shares depend on relative TSR; FY2024–FY2026 awards vested at 190.7% after CSW ranked in the 78.1st percentile of the Russell 2000. Ownership guidelines are six times salary for the CEO and three times for other named officers. Governance includes one voting class, annual majority-elected directors, independent committees, and a lead independent director, although Joseph Armes combines CEO and chair roles.

Insider activity offers little valuation comfort. Since September 2021, filings show approximately $39.2 million of sales and only one code-P purchase: director Darron Ash’s $76,986 purchase in March 2026. After July 4, Armes sold 3,000 planned shares; COO Don Sullivan sold about $1.56 million and SVP Jeff Underwood $0.25 million without a 10b5-1 notation. Those sales do not predict a decline, but the absence of broad buying matters when management calls repurchases attractive.

Capital allocation is capable but not exemplary. Rapid integration, cheap bolt-ons, sensible repurchase prices, and liquidity deserve credit. MARS’s full price, scale-weighted incentives, low insider economic ownership, and willingness to keep an acquisition pipeline active before ROIC recovers deserve scrutiny.

8. Changes and Headwinds — Last Two Years

Four transitions overlap: net cash became leverage; Aspen and MARS expanded Contractor; refrigerant rules altered inventory and demand timing; and EBS began exiting Greco. The comparisons are consequently noisy.

The positive change is integration. Contractor margin recovered faster than expected, MARS synergies arrived early, SRS margin expanded, and the mix shifted toward Contractor at 78% of Q1 sales. Cash conversion improved and net debt declined. The negative is that price and volume must now survive tougher comparisons. Aspen moved into organic results during Q1; MARS follows in November. Aspen also compares against last year’s refrigerant-transition demand.

July Contractor price increases of 3%–5% seek to recover steel, aluminum, plastics, and freight rather than expand margin. SRS implemented staged increases. Management reported no unusual pre-buy and normalized distributor inventories, but subsequent sell-through must validate that claim.

Tariffs and sourcing remain variables. Roughly 45%–50% of Contractor cost is domestic, low-30s comes from Vietnam, high-single digits from Thailand, and around 10% from China. Acquisitions repeatedly reintroduce China exposure. Freight and trade policy can change cost before pricing catches up.

Greco is the visible cleanup. Q1 U.S. revenue was $3.1 million with an $0.8 million pretax loss; Canadian revenue was $2.4 million with an $0.3 million loss excluding exit costs. Another $1.0–$1.5 million of exit expense is expected, and the U.S. operation remained held for sale. The amounts are small, but the episode demonstrates that niche status does not guarantee a moat.

Interest is the lasting cost of the strategy. Management expects about $48 million in FY2027, versus virtually none before the acquisitions. Debt reduction converts directly into earnings and resilience. Another large transaction would delay that benefit and restart the integration clock.

One reporting correction warrants attention. CSW amended its FY2026 earnings release because acquisition-inclusive Q4 Contractor growth used the wrong prior-year acquired revenue. The rate fell from 5.5% to 0.7%; reported Contractor organic growth remained 2.6% and consolidated organic growth 2.8%. The error does not change GAAP results, but it weakens confidence in bespoke pro-forma KPIs. Filed, definition-stable measures should govern.

9. Risk Analysis

The asymmetric risk is valuation layered onto capital-return uncertainty. The balance sheet can absorb an ordinary downturn; the multiple may not. Slower growth would reduce both earnings and the multiple investors pay. The upside risk to caution is that trailing results understate a full year of MARS at its achieved margin while cash paydown accelerates per-share growth.

The impairment test matters even without an immediate charge. Goodwill and intangibles are supported by future Contractor cash flows. A non-cash impairment would not itself drain liquidity, but it would reveal that sellers captured more economics than shareholders. Segment margin and reporting-unit assumptions matter more than the label.

Monitoring should be quantitative: organic price and volume separately; Contractor operating margin above 25%; cash-conversion cycle moving toward 150 days; credit leverage below 2×; and ROIC first above 12% and ultimately near 15%. Failure on two or more together would be more informative than a single miss.

10. Valuation Discussion — Embedded Expectations

This section describes what the market price implies and how outcomes vary; the investment opinion appears only in Claude’s Take.

Current bridge and denominator hierarchy

The September 2 close of $301.80 multiplied by 16.293 million shares gives a $4.917 billion equity value. Adding $810.0 million of net debt and $19.0 million of redeemable non-controlling interest produces a $5.746 billion enterprise value. The bridge uses current shares and the latest filing balance sheet rather than the stale price in third-party enterprise-value feeds.

The spread is the analysis. A valuation built on covenant EBITDA would fall to 16.7×, but that denominator includes pro-forma acquisition earnings, stock compensation, transaction and integration cost, and other addbacks. A GAAP-only multiple understates current cash productivity because amortization is large and non-cash. The impairment-only and company-adjusted columns show a defensible range without pretending the accounting choice is settled.

Peer context

Seven imperfect peers were repriced to September 2 while retaining their latest trailing denominators. Watsco, Applied Industrial, and MSC Industrial are lower-margin channel analogues; Lennox and AAON are equipment OEMs with different capital intensity; Graco resembles SRS’s high-margin specialty model; Watts is the closest branded flow/building-products analogue. Median trailing multiples were 2.83× sales, 18.2× EBITDA, 20.3× EBIT, 28.1× earnings, and 21.3× free cash flow.

On GAAP metrics, CSW trades 74% above the median on sales, 18% on EBITDA, 46% on EBIT, 47% on earnings, and 60% on free cash flow. Using company-adjusted EBITDA reduces the EBITDA premium to roughly 4%. That collapse in the premium illustrates how much of the relative case depends on treating amortization and integration costs as non-economic. Peer data are contextual rather than authoritative: AAON and Applied Industrial denominators are one quarter older, and AAON’s free cash flow is depressed by a capacity build.

An own-history percentile is omitted. The vendor’s series breaks when CSWI changed ticker to CSW in June 2025: its current P/S percentile conflicts sharply with the July result, and the old symbol no longer resolves. Absolute, filing-reconciled multiples are more reliable than an unstitched percentile.

Reproduction value and earnings power

A Greenwald-style asset-value test does not support the capitalization. June attributable book equity was $1.074 billion versus $4.917 billion of market value, and tangible equity was negative $452 million. Purchased goodwill and intangibles include negotiated synergies and cannot serve as a conservative reproduction floor. Brand creation and channel access certainly cost more than tangible book, but reverse-engineering an unobservable brand value to match the share price would be circular.

No-growth earnings power produces the same message. Filing-derived free cash flow to the firm is about $170.4 million: equity FCF plus after-tax net interest. Capitalized at 9.0%–10.5%, enterprise earnings-power value is approximately $1.62–$1.89 billion; after net debt and non-controlling interest, that supports only 16%–22% of current equity capitalization. Even a generous $220 million normalized FCFF, crediting full MARS/Aspen contribution and better working capital, supports 26%–33%. This EPV comparison shows that most market value represents franchise growth rather than no-growth cash earnings.

Reverse DCF

At $5.746 billion of enterprise value, 3% terminal growth, and a five-year explicit period, the $170.4 million reported FCFF base must compound approximately 19.4% annually at a 9% discount rate, 23.7% at 10%, or 25.8% at 10.5%. Beginning with a generous normalized $220 million still requires approximately 13.0%, 17.0%, or 18.9% annual growth. The U.S. Treasury’s September 2 curve showed a 4.79% ten-year yield, which makes a single-digit discount rate already accommodating for a 1.35-beta small-cap industrial.

Another way to state the expectation: to generate a 10% five-year shareholder return with flat shares, cumulative dividends around $7.38, $250 million of ending net debt, and an 18× exit EBITDA multiple, CSW needs about $448 million of year-five EBITDA. That can come from $1.95 billion of revenue at a 23% margin, $1.79 billion at 25%, or $1.60 billion at 28%. From $1.170 billion trailing revenue, those combinations require 10.8%, 8.9%, or 6.5% annual revenue growth. Margin is the crucial release valve.

Conditional five-year scenarios

Includes scenario-specific cumulative dividends. These are conditional outcomes, not targets.

The base scenario assumes substantial operating success: 6% growth, margin above the current GAAP run rate, and $560 million of net-debt reduction. It still produces only a 7% modeled annual return because the entry multiple is high. Terminal multiple is the largest sensitivity: holding base inputs constant, a 14×, 18×, or 22× exit creates approximately 1.6%, 7.0%, or 11.5% annual returns. Growth, margin, debt paydown, and share count matter, but the price paid for duration dominates.

The market may be correctly recognizing recurring replacement demand, early MARS synergy, high Contractor margins, low capex, and excellent cash conversion. It may be too readily assuming that adjusted economics persist, future acquisitions remain inexpensive, mid-to-high-single-digit organic growth survives anniversaries, and leverage falls rapidly while buybacks continue. The current capitalization requires more than a good business; it requires sustained execution.

11. Variant Perception

What the optimistic view gets right

The bullish view is no longer just a management promise. Contractor margin recovered to 27.2%, MARS reportedly reached its target early, organic price and volume both grew, and free cash flow supported both shareholder returns and debt reduction. A broad parts basket can create distributor relevance, refrigerant rules preserve repair as well as replacement demand, and the June filing likely understates a full twelve months of MARS earnings. If Contractor stays in the high-20s and credit leverage falls quickly, trailing ROIC can improve mechanically and organically.

What that view may miss

Integration margin is not acquisition return. A 30% EBITDA margin on MARS’s disclosed run rate still produces only a mid-single-digit EBITDA yield on price. Customer lists and goodwill absorbed almost the entire consideration, so there is little tangible cushion. The current multiple capitalizes future cash growth that Q1 alone cannot establish, while management no longer publishes standalone MARS or Aspen economics.

The organic headline also needs qualification. Two Aspen months moved into organic growth, MARS changes categories in November, and summer is the seasonal high-water mark. A 5.3% quarter after a -2.1% year may be normalization rather than a new structural rate. Distributor sell-through and unit volume after July price increases will distinguish the two.

What the cautious view gets wrong

The skeptical view can over-anchor to FY2026’s acquisition accounting and ignore operating progress. Treating all amortization as equivalent to maintenance capex understates a business whose physical capex is less than 2% of sales. Assuming refrigerant regulation forces replacement ignores EPA service-component rules. Describing MARS integration as wholly unproven is now stale. CSW has repeatedly converted earlier acquisitions into higher Contractor margins; another successful integration is plausible.

The actual disagreement

The controversy is not “good company or bad company.” It is whether the acquired capital can earn a return commensurate with the premium already embedded in the security. Evidence can resolve that disagreement within several quarters: organic growth after anniversary changes, Contractor margin through seasonal lows, cash-conversion-cycle normalization, and filing-derived ROIC. The market currently gives more weight to the numerator’s improvement than to the denominator’s size.

12. Fact vs. Interpretation

The table matters because several load-bearing points are estimates rather than disclosed facts. MARS’s standalone margin, cross-selling, share gain, and mature acquisition return are management claims or investor inferences. The filing proves consolidated and segment outcomes; it does not prove causation within the portfolio.

13. Open Questions

1. What were MARS and Aspen standalone revenue, EBITDA, free cash flow, and organic growth in Q1, on consistent definitions?
2. How much of Contractor’s 5.9% organic growth came from price, legacy unit volume, Aspen anniversary classification, refrigerant mix, and distributor stocking?
3. Can Contractor sustain at least 25% operating margin through the December seasonal low and after MARS becomes organic?
4. What is management’s explicit bridge from the current 9.6% filing-derived ROIC to a mid-teens acquisition return, including timing and reinvestment?
5. How much working capital can be released as Aspen/MARS inventory and systems normalize, and why have receivable days increased?
6. Will capital prioritize debt reduction while the shares trade at a premium, or will buybacks and another acquisition compete for cash?
7. Why does the annual incentive plan omit ROIC, organic growth, and per-share free cash flow after the largest acquisition year in company history?
8. Which product categories have stable five-to-eight-year market share, reorder rates, or distributor-retention data sufficient to test the moat directly?
9. What is the final timing and cash cost of the Greco U.S. sale and Canadian exit, and what continuing margin should EBS earn afterward?
10. Can the company reconcile the Q1 repurchase inconsistency and provide a stable acquisition-inclusive KPI after the FY2026 correction?
11. How much tariff exposure remains by country, and what lag exists between raw-material changes and distributor price realization?
12. What succession structure follows the extension of the CEO award deadline to 2032, and how will the board separate operating execution from acquisition discipline?

These questions are not prerequisites for understanding the company. They are the missing data required to distinguish an excellent integrator from a good operator paying too much for growth.

14. What Must Be True

For the operating thesis to strengthen, the following must become visible in filings rather than only calls:

• Organic revenue remains above 4% through at least two more quarters, including MARS’s November anniversary, with positive unit volume rather than price alone.
• Contractor operating margin remains above 25% through seasonality, demonstrating that the Q1 high is not weather or mix only.
• MARS’s reported 30% EBITDA margin translates into consolidated cash earnings; company-adjusted EBITDA growth is matched by per-share free-cash-flow growth.
• The cash-conversion cycle returns toward 150 days, with inventory and receivables normalizing rather than shifting between accounts.
• Credit-agreement leverage falls below 2× without relying on another pro-forma addback expansion, and no large acquisition resets the denominator.
• Filing-derived ROIC exceeds 12% and then approaches 15% as MARS seasons. This is the decisive bridge from integration success to value creation.
• Greco exits without another material impairment, and EBS settles into a sustainable margin above 15% rather than extrapolating one mid-20s adjusted quarter.
• Buybacks at least offset stock compensation and issuance, but debt reduction takes precedence when the market multiple is elevated.

Evidence that would weaken the thesis is equally concrete: organic volume turns negative after pricing; Contractor margin falls below 23%; net leverage stalls above 2.5×; trailing free cash flow falls below $140 million despite full MARS contribution; or management announces another large transaction before existing capital earns above its cost.

The time horizon is unusually favorable for falsification. Q2 tests Aspen’s difficult comparison and July pricing. Q3 includes the MARS anniversary and a seasonal margin step-down. The FY2027 10-K supplies a full acquisition-year cash and capital base. By then, “too early” should no longer explain a single-digit return.

15. Source Appendix

Primary company evidence:

• CSW Industrials FY2026 Form 10-K, SEC, filed May 26, 2026. Business, risks, five-year financials, segments, acquisitions, debt, and controls.
• CSW Industrials Q1 FY2027 Form 10-Q, SEC, filed July 30, 2026. Current financials, segments, purchase accounting, leverage, repurchases, Greco, and controls.
• Q1 FY2027 earnings release, CSW Industrials, July 30, 2026. Adjusted reconciliations and credit-agreement leverage.
• Corrected FY2026 earnings 8-K/A, SEC, May 26, 2026. Corrected acquisition-inclusive Contractor comparison and FY2026 non-GAAP bridge.
• 2026 definitive proxy, SEC, July 16, 2026. Incentives, ownership, compensation, governance, and board structure.
• 2026 annual-meeting Form 8-K, SEC, August 31, 2026. Voting results and board transition.
• FY2027 Q1 earnings-call transcript, July 30, 2026. Machine-generated; used for qualitative remarks and reconciled to filings.

Industry and competitor evidence:

• Watsco 2025 Form 10-K, SEC, February 27, 2026. HVAC/R market size, distribution structure, contractors, and suppliers.
• Watsco Q2 2026 release, July 29, 2026. Current equipment and non-equipment sales.
• Lennox Q2 2026 release, July 29, 2026. Residential and commercial HVAC demand comparison.
• AHRI June 2026 statistical release, August 14, 2026. Central-air-conditioner and heat-pump shipments.
• EPA HFC phasedown frequently asked questions, accessed September 3, 2026. R-410A service-component rules.
• International Building Code, Chapter 7, accessed September 3, 2026. Fire and smoke protection requirements.
• DiversiTech, Nu-Calgon, and Oatey, accessed September 3, 2026. Competitive breadth and fulfillment claims.

Market and model evidence:

• AZI CSW adjusted price history, through September 2, 2026. Price, return, and event-map calculations.
• FactorsToday CSW stock information, factor loadings, and related stocks, pulled September 3, 2026. Empirical beta, factor, volatility, and similarity context.
• ROIC.ai, accessed September 3, 2026. Peer trailing fundamentals and a historical CSW ROIC cross-check; CSW’s current valuation bridge was rebuilt from filings because the third-party price and trailing periods were stale.
• U.S. Treasury daily yield curve, September 2, 2026. Discount-rate context.

All calculated figures use unrounded source data where available and may differ slightly from displayed arithmetic. Management-defined adjusted results are labeled; filing-derived calculations are described. No current short-interest conclusion is included because the authenticated vendor endpoint could not be validated. The ticker-change discontinuity also makes own-history valuation percentiles unreliable, so they are omitted.